Ondo InsurTech expects to be profitable in the second half of next year as demand for its LeakBot device grows. Revenue is forecast to jump 70% to around £5 million, with strong expansion in the US and Europe.
ImmuPharma has raised £2.91 million in an oversubscribed funding round to develop its P140 autoimmune technology. The money will also support talks with big pharma on potential licensing deals.
In mining news, Oriole Resources has wrapped up Phase 5 drilling at its Bibemi gold project in Cameroon. The program covered nearly 7,000 metres, with assay results due later this quarter.
And Empire Metals has reported strong results from metallurgical testing at its Pitfield Project in Western Australia. The tests confirm a simple process can produce high-purity titanium dioxide, with titanium recoveries hitting 91%.
Follow us and subscribe on Youtube, our social channels and of course on proactiveinvestors.co.uk
